Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining “No Evidence of Disease Activity” in Multiple Sclerosis
Editorial - Volume 19, Issue 2 - March 2017
Frequency of and Factors Associated with a Proxy for Critical Falls Among People Aging with Multiple Sclerosis
The Functional Gait Assessment in People with Multiple Sclerosis
Lower Endurance and Strength of Core Muscles in Patients with Multiple Sclerosis
Fatigue, Physical Activity, Quality of Life, and Fall Risk in People with Multiple Sclerosis
Dimethyl Fumarate
A Topical Adhesive Containing Anesthetic and Heating Components to Reduce Injection Pain with Subcutaneous Multiple Sclerosis Medications
Is Exercise Training Beneficial in Progressive Multiple Sclerosis?
Abstracts from the Fifth Conference of the International Multiple Sclerosis Cognition Society
Editorial - Volume 19, Issue 1 - January 2017
Screening Instruments for the Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis
Laquinimod Safety Profile
Stopping Disease-Modifying Therapy in Nonrelapsing Multiple Sclerosis
Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis–Related Disability
Multidisciplinary Management of Sexual Dysfunction, Perineal Pain, and Elimination Dysfunction in a Woman with Multiple Sclerosis
Immediate Effect of a Service Dog on Walking Speed in Individuals with Multiple Sclerosis and Gait Dysfunction: A Pilot Study
A Framework of Care in Multiple Sclerosis, Part 2
Poster Abstracts from the Sixth International Symposium on Gait and Balance in Multiple Sclerosis
Screening Tools for Anxiety in People with Multiple Sclerosis
Assessment and Treatment of Psychiatric Distress, Sexual Dysfunction, Sleep Disturbances, and Pain in Multiple Sclerosis
Effect of Comorbidities on Outcomes of Neurorehabilitation Interventions in Multiple Sclerosis
Individual and Co-occurring SNAP Risk Factors
A Framework of Care in Multiple Sclerosis, Part 1
Antidepressant Drug Treatment in Association with Multiple Sclerosis Disease-Modifying Therapy
Comorbidity in Multiple Sclerosis
Editorial - Volume 18, Issue 5 - September 2016
Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies
Correction of Footdrop Due to Multiple Sclerosis Using the STIMuSTEP Implanted Dropped Foot Stimulator
The Transition to Secondary Progressive Multiple Sclerosis